You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Influenza

Amantadine, oseltamivir and zanamivir for the treatment of influenza

  • Technology appraisal guidance
  • Reference number: TA168
  • Published:  25 February 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA168 Influenza - zanamivir, amantadine and oseltamivir (review): Appendix B - proposal paper presented to the Institute's Guidance Executive

TA168 Influenza - zanamivir, amantadine and oseltamivir (review): Appendix B - proposal paper presented to the Institute's Guidance Executive TA168 Influenza - zanamivir, amantadine and oseltamivir (review): Appendix B - proposal paper presented to the Institute's Guidance Executive
29 November 2013
(611.89 Kb 58 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 28 November 2013

Back to top